Molecular Alterations Obtained by High Throughput Methods in Multiple Myeloma Patients with Recurrent or Refractory to Heavy Treatment Regimens Could Guide Alternative Targetted Therapies

KUZU I., SEVAL G. C., YÜKSEL S., Kaygusuz G., DALVA K., ÖZCAN M., ...Daha Fazla

Multiple miyelom AMP kongre 2021, 30 Nisan - 01 Mayıs 2021

  • Yayın Türü: Bildiri / Tam Metin Bildiri
  • Ankara Üniversitesi Adresli: Evet